Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Works matching IS 11732563 AND DT 2020 AND VI 40 AND IP 3
Results: 11
1
2
Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 197, doi. 10.1007/s40261-020-00887-6
- By:
- Publication type:
- Article
3
Response to Comment on: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study".
- Published in:
- 2020
- By:
- Publication type:
- Letter
4
Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study".
- Published in:
- 2020
- By:
- Publication type:
- Letter
5
Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 211, doi. 10.1007/s40261-020-00888-5
- By:
- Publication type:
- Article
6
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS).
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 269, doi. 10.1007/s40261-020-00886-7
- By:
- Publication type:
- Article
7
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 279, doi. 10.1007/s40261-020-00885-8
- By:
- Publication type:
- Article
8
Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 259, doi. 10.1007/s40261-019-00883-5
- By:
- Publication type:
- Article
9
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 249, doi. 10.1007/s40261-019-00882-6
- By:
- Publication type:
- Article
10
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 227, doi. 10.1007/s40261-019-00881-7
- By:
- Publication type:
- Article
11
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 237, doi. 10.1007/s40261-019-00879-1
- By:
- Publication type:
- Article